Jinyu Bio-Technology Co Ltd Class A 600201
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥6.78
- Day Range
- ¥6.93–7.41
- 52-Week Range
- ¥5.62–11.03
- Bid/Ask
- ¥7.30 / ¥7.31
- Market Cap
- ¥8.18 Bil
- Volume/Avg
- 52.1 Mil / 12.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 26.15
- Price/Sales
- 5.30
- Dividend Yield (Trailing)
- 1.10%
- Dividend Yield (Forward)
- 1.10%
- Total Yield
- 1.10%
Company Profile
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,654
- Website
- http://www.jinyu.com.cn
Comparables
Valuation
|
Metric
|
600201
|
002567
|
001313
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.15 | — | 198.84 |
Price/Book Value | 1.52 | 1.48 | 2.15 |
Price/Sales | 5.30 | 0.33 | 0.84 |
Price/Cash Flow | 15.52 | 8.04 | 12.45 |
Price/Earnings
600201
002567
001313
Financial Strength
|
Metric
|
600201
|
002567
|
001313
|
|---|---|---|---|
Quick Ratio | 2.72 | 0.45 | 1.19 |
Current Ratio | 3.20 | 1.11 | 1.63 |
Interest Coverage | 53.65 | −2.16 | 0.49 |
Quick Ratio
600201
002567
001313
Profitability
|
Metric
|
600201
|
002567
|
001313
|
|---|---|---|---|
Return on Assets (Normalized) | 3.52% | −4.86% | 0.22% |
Return on Equity (Normalized) | 4.51% | −14.79% | 0.41% |
Return on Invested Capital (Normalized) | 3.47% | −4.76% | 1.04% |
Return on Assets
600201
002567
001313
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Bpqfjwhdd | Krx | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Xxrfpkrdt | Xrqkmxw | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Sdxkwsf | Vkkpzgw | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Fpqskzkww | Mvslft | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Lscyrnfc | Jhpm | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Wlmprlnt | Tjzl | $28.1 Bil | |||
| Moderna Inc
MRNA
| Zltgkjm | Hpqv | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Rxglzvcd | Dhhg | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Npkwpfznm | Bncwzz | $13.4 Bil | |||
| Incyte Corp
INCY
| Cwyzjqz | Tshlk | $12.7 Bil |
United States